177 related articles for article (PubMed ID: 16928654)
21. A comparison of the effect of high-dose methylprednisolone with conventional-dose prednisolone in acute lymphoblastic leukemia patients with randomization.
Yetgin S; Gürgey A; Tuncer AM; Cetin M; Ozbek N; Sayli T; Güler E; Kara A; Olcay L; Duru F; Gümrük F; Atahan L; Tunçbilek E
Leuk Res; 1998 Jun; 22(6):485-93. PubMed ID: 9678714
[TBL] [Abstract][Full Text] [Related]
22. Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia.
Nakase K; Kita K; Miwa H; Nishii K; Shiku H; Nasu K; Dohy H; Kyo T; Kamada N; Tsutani H
Cancer Detect Prev; 2001; 25(4):394-405. PubMed ID: 11531016
[TBL] [Abstract][Full Text] [Related]
23. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia.
Drexler HG; Thiel E; Ludwig WD
Leukemia; 1991 Aug; 5(8):637-45. PubMed ID: 1886419
[TBL] [Abstract][Full Text] [Related]
24. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia.
Abdelhaleem M
Exp Mol Pathol; 2007 Aug; 83(1):138-41. PubMed ID: 17434163
[TBL] [Abstract][Full Text] [Related]
25. Thalidomide increases in vitro sensitivity of childhood acute lymphoblastic leukemia cells to prednisolone and cytarabine.
Czyzewski K; Zaborowska A; Styczyński J
Arch Immunol Ther Exp (Warsz); 2006; 54(5):341-5. PubMed ID: 17031469
[TBL] [Abstract][Full Text] [Related]
26. In vivo and in vitro expression of myeloid antigens on B-lineage acute lymphoblastic leukemia cells.
Hara J; Kawa-Ha K; Yumura-Yagi K; Kurahashi H; Tawa A; Ishihara S; Inoue M; Murayama N; Okada S
Leukemia; 1991 Jan; 5(1):19-25. PubMed ID: 1705635
[TBL] [Abstract][Full Text] [Related]
27. The effect of high-dose methylprednisolone on CD34-positive bone marrow cells in the children with acute myeloblastic leukemia.
Tuncer AM; Hiçsönmez G; Gümrük F; Albayrak D; Duru F; Güzel E; Sayli T
Turk J Pediatr; 1995; 37(4):345-9. PubMed ID: 8560602
[TBL] [Abstract][Full Text] [Related]
28. In vitro determination of apoptotic effect of heparin on lymphoblasts by using flow cytometric DNA analysis and measurements of caspase-9 activation and cytochrome C level.
Erduran E; Zaman T; Deger O; Tekelioglu Y; Bahadir A
J Pediatr Hematol Oncol; 2012 Jan; 34(1):e26-9. PubMed ID: 22052169
[TBL] [Abstract][Full Text] [Related]
29. Comparative measurement of spontaneous apoptosis in pediatric acute leukemia by different techniques.
Savitskiy VP; Shman TV; Potapnev MP
Cytometry B Clin Cytom; 2003 Nov; 56(1):16-22. PubMed ID: 14582133
[TBL] [Abstract][Full Text] [Related]
30. Lymphoblastic transformation of chronic myelomonocytic leukemia in an infant.
Yamamoto M; Nakagawa M; Ichimura N; Ohtsuki F; Ohtsuka Y; Tsujino Y; Tanaka A; Kamiya T; Wada H
Am J Hematol; 1996 Jul; 52(3):212-4. PubMed ID: 8756090
[TBL] [Abstract][Full Text] [Related]
31. The effect of short-course high-dose methylprednisolone on peripheral blood lymphocyte subsets in children with acute leukemia during remission induction treatment.
Tunç B; Oner AF; Hiçsönmez G
Leuk Res; 2003 Jan; 27(1):19-21. PubMed ID: 12479848
[TBL] [Abstract][Full Text] [Related]
32. [Acute mixed lineage leukemia showing resistance to AML and ALL therapy].
Kawashima H; Iizuka Y; Kondou W; Hirota H; Okuyama Y; Kanou M; Ichii S; Murakami J; Tsuchiya T; Sawada T
Rinsho Ketsueki; 1993 May; 34(5):643-8. PubMed ID: 7686236
[TBL] [Abstract][Full Text] [Related]
33. Changes in the MDR1 gene expression after short-term ex vivo therapy with prednisolone have prognostic impact in childhood acute lymphoblastic leukemia.
Janiszewska H; Styczynski J; Kolodziej B; Wysocki M; Haus O
Ann Hematol; 2009 Dec; 88(12):1193-8. PubMed ID: 19352661
[TBL] [Abstract][Full Text] [Related]
34. High-dose methylprednisolone for children with acute lymphoblastic leukemia and unfavorable presenting features.
Hiçsönmez G; Gümrük F; Zamani PV; Tuncer MA; Yetgin S; Gürgey A; Atahan L; Ozsoylu S
Eur J Haematol; 1997 Jan; 58(1):26-31. PubMed ID: 9020370
[TBL] [Abstract][Full Text] [Related]
35. Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test.
Rix M; Birkebaek NH; Rosthøj S; Clausen N
J Pediatr; 2005 Nov; 147(5):645-50. PubMed ID: 16291357
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.
Styczynski J; Kurylak A; Wysocki M
Anticancer Res; 2005; 25(3B):2253-8. PubMed ID: 16158972
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment of refractory anemia by high-dose methylprednisolone associated with an increment in CD68-positive cells in bone marrow.
Motomura S; Motoji T; Okutomi K; Nishikawa T; Kasajima T; Mizoguchi H
Am J Hematol; 2001 Feb; 66(2):80-4. PubMed ID: 11421303
[TBL] [Abstract][Full Text] [Related]
38. High-dose oral methylprednisolone therapy in childhood hemangiomas.
Uysal KM; Olgun N; Erbay A; Sarialioğlu F
Pediatr Hematol Oncol; 2001; 18(5):335-41. PubMed ID: 11452405
[TBL] [Abstract][Full Text] [Related]
39. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic value of early treatment response in children with acute myeloid leukemia].
Tie LJ; Gu LJ; Song DL; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J; Wang YP; Zou JY
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1837-40. PubMed ID: 17054861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
